Physician profile
Jeffrey A Bash
NPI 1497868053
$839,955.67
in general payments reported to CMS, 2019-2025
13 companies · $74K in 2025
The $74K reported for 2025 was more than what 90% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201K · 2020: $161K · 2021: $193K · 2022: $53K · 2023: $79K · 2024: $78K · 2025: $74K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $119K · Consulting Fee: $98K · Travel and Lodging: $13K · Food and Beverage: $2,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $118,753.68 |
| Consulting Fee | $98,039.18 |
| Travel and Lodging | $12,583.20 |
| Food and Beverage | $2,170.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $734,034.72 | 2019-2025 | Amp, Solus Alif, Ltx |
| Spinefrontier, INC. | $100,451.58 | 2019-2023 | Vbr |
| Orthofix Medical, INC. | $3,394.67 | 2019 | |
| Providence Medical Technology, INC. | $1,030.29 | 2019 | |
| Corelink, LLC | $372.43 | 2019-2020 | |
| Royal Biologics, INC. | $205.22 | 2024 | |
| Stryker Corporation | $170.06 | 2023 | Capri Corpectomy Cage System |
| Avanos Medical | $149.74 | 2019 | |
| Djo, LLC | $55.62 | 2019-2024 | Cmf |
| Vertex Pharmaceuticals Incorporated | $32.21 | 2025 | |
| Zimvie INC. | $27.59 | 2023 | |
| Depuy Synthes Sales INC. | $17.48 | 2024 | Orthovisc, Monovisc |
| Sanofi-Aventis U.S. LLC | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Bash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.